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Abstract
Photoaging induced by both ultraviolet and visible light has been shown to lead to increased inflammation and dysregulation
of the extracellular matrix. Standardized extract of the Polypodium leucotomos fern, PLE, possesses anti-inflammatory and
antioxidant properties, and has been shown to potentially mitigate photoaging through various mechanisms. This comprehensive review presents the data available on the effects of P. leucotomos extract on UV and VL-induced photoaging in vitro
as well as in vivo in murine and human models.
Keywords Polypodium leucotomos · Photoaging · Visible light · Ultraviolet light
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1 Introduction
Electromagnetic radiation emitted by sunlight as it
reaches the surface of the earth consists of ultraviolet A
(320–400 nm) and ultraviolet B (290–320 nm), visible
(400–700 nm), and infrared (> 700 nm) spectra [1]. It is
established that UV radiation (UVR) contributes to photoaging, which encompasses the clinical and histological changes from chronic solar radiation exposure due to
increased inflammation and oxidative burden. Although not
as extensively studied as UVR, visible light (VL) has also
been reported to induce photoaging changes [2–6].
The structural integrity of the skin relies on the extracellular matrix (ECM) and its fibrillary proteins, collagen and elastin, which are secreted by fibroblasts [4].
UVR-induced cell membrane lipid oxidation by reactive
oxygen species (ROS) leads to the generation of arachidonic acid, which is converted by cyclooxygenase (COX)
enzymes into eicosanoids, leading to inflammation [7,
8]. UVR-induced expression of the transcription factor
activator protein (AP)-1 leads to ECM damage through
over expression of matrix metalloproteinases (MMPs)
which degrade collagen and elastin [4, 8–10]. AP-1 also
blocks the effect of tumor growth factor (TGF)-β which
is involved in collagen I and III gene expression and
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synthesis [11]. Photoaging also involves elastase activity,
reduced expression of tissue inhibitors of matrix metalloproteinases (TIMPs), fibrillin, and altered cellular stress
response proteins, such as heat shock proteins [12]. Histologic changes of photoaging include increased inflammatory cells, elastotic material, glycosaminoglycans and
disordered collagen which manifest clinically as wrinkles,
and disordered skin remodeling and wound healing [2, 13,
14]. While much of the information on photoaging has
been studied in relation to UVR, VL has also been shown
to induce ROS and MMP expression [6].
Although non-tinted topical sunscreens can prevent
actinic damage from UVR, they are not protective against
VL-induced changes [15]. Traditional sunscreens containing organic ultraviolet (UV) filters have also increasingly
been scrutinized for their effects on the environment [16].
These limitations have garnered an increased interest in
environmentally safe topical sunscreens and oral polyphenol
compounds, the latter to provide systemic protection against
a broad wavelengths of solar radiation through increasing
plasma and skin antioxidant levels and mitigating the detrimental effects of ROS [17]. The concept of oral antioxidants
used as photoprotection, as compared to commonly utilized
topical agents, has recently become seriously proposed in
the field of photoprotection.
The Polypodium leucotomos fern from the family of
Polypodiaceae is found in Central and South America [18].
Standardized extract of P. leucotomos, herein referred to
as PLE, is an antioxidant available as an over the counter
oral supplement; Polypodium extract as a photoprotectant
was patented by **Pathak et al. in 1995 (Patent number:
US5614197) and the combination of phenolics and other
ingredients observed in this controlled extract were subsequently patented in 2008 and registered as Fernblock® (Cantabria Labs, Madrid, Spain) [19]. Studies have shown that
PLE decreases UV-induced erythema, DNA damage, epidermal hyperproliferation, and acute PUVA (psoralen + UVA)
induced phototoxic reactions [9, 20–23]. It has been shown
to down-regulate the exacerbation of polymorphous light
eruption [24, 25]. The photoprotective properties of oral
PLE are thought to be due to its antioxidative and antiinflammatory capacity [17, 26].
This comprehensive, in-depth review aims to explore the
data available on the effects of P. leucotomos on UV and
VL-induced photoaging. This is an update of a previous
review published in 2016 [27]. The effects on UV-induced
changes will be discussed first, followed by those induced by
VL. Each section is will be subdivided into in vitro studies,
then animal and human studies. Alterations in molecular
photoaging biomarkers as a result of UV or VL irradiation
in the skin will be emphasized. It should be noted that except
as noted, all studies used PLE preparation of Fernblock® or
its precursor.
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2 Studies involving ultraviolet radiation
and PLE
PLE’s effects on UV-induced photoaging has been investigated in vitro in human dermal fibroblasts and keratinocytes, and in vivo in murine models and humans (Table 1).

2.1 In vitro
In a study by Philips et al., the effects of post-irradiation incubation with PLE on cell membrane damage as
measured by LDH, lipid peroxidation, matrix metalloprotease (MMP)-1 and elastin were assessed in UVR (UVA
1.8 J/cm2 or UVB 2.5 mJ/cm2) irradiated human dermal
fibroblasts and human epidermal keratinocytes [10]. PLE
was shown to significantly inhibit cellular LDH release
from fibroblasts but not from keratinocytes. PLE also significantly inhibited UVR-induced lipid peroxidation and
decreased UVR-induced MMP-1 generation from fibroblasts and keratinocytes. Following UVR exposure, an
increase generation of elastin was noted from fibroblasts
and keratinocytes, regardless of treatment with PLE; however, the PLE-related increase was a reflection of wellformed elastin fiber deposition. The authors postulated
that PLE may prevent photoaging by preserving membrane
integrity and inhibiting MMP-1 synthesis while reversing intrinsic aging-associated loss of normal elastic fibers
[10]. In another study by Philips et al., the effect of various
PLE concentrations on collagen and TGF-β expression of
UV-irradiated (UVA 1.8 J/cm2 or UVB 2.5 mJ/cm2) human
neonatal dermal fibroblasts. Cells were pretreated for 24 h
with PLE doses from 0 to1%. PLE treatment resulted in
increased TGF-β, type I collagen, and type V collagen
levels in the cell media of irradiated fibroblasts. No significant changes were noted in type III collagen expression. These effects on the ECM were thought to be due to
PLE’s antioxidative properties and possible cell-specific
up-regulation of TGF-β expression [28].
Philips et al. also evaluated the effect of various PLE
concentrations (0–0.1%) on generation of elastase, tissue
inhibitors of matrix metalloproteinases (TIMPs), fibrillin,
TGF-β, and heat shock proteins (HSP) by keratinocytes
after UVR (7.5 mJ/cm2 UVA or 7.5 mJ/cm2 UVB). HSP
are induced by cellular stress and aid in stabilizing proteins. HSP-27 is linked to epidermal differentiation and
HSP-70 is anti-inflammatory and prevents UVB radiation
induced epidermal damage [29, 30]. PLE inhibited elastase
activity, stimulated TIMP-1, TIMP-2, fibrillin-1, fibrillin-2
and TGF-β expression and stimulated synthesis of HSP-27
and HSP-70 by irradiated keratinocytes, thereby strengthening ECM integrity [12].
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Table 1  Effects of Polypodium leucotomos extract on ultraviolet radiation-induced photoaging in vitro and in vivo
References

Cell types/substrates

Effect of PLE following UV exposure

Philips et al. [10]

Fibroblasts, keratinocytes

↓LDH release (fibroblasts only)
↓MMP-1
↑Elastin

Philips et al. [28]

Fibroblasts

↑TGF-β
↑Type I collagen
↑Type V collagen

Philips et al. [12]

Keratinocytes

↓Elastase
↑TIMP-1
↑TIMP-2
↑Fibrillin-1
↑Fibrillin-2
↑TGF-β
↑HSP-27 and HSP-70

Alonso-Lebrero et al. [31]

Fibroblasts, keratinocytes

↑Cell survival (fibroblasts and keratinocytes)
↑Cell proliferation (fibroblasts and keratinocytes)
↓Cytoskeletal disorganization (fibroblasts only)

Capote et al. [32]

Trans-urocanic acid, Fibroblasts

↓Cis-UCA (± H2O2)
↓Trans-UCA photodecomposition (in the presence of TiO2)
↑Fibroblast survival

Janczyk et al. [35]

Keratinocytes

↓TNF-α
↓NO
↓i-NOS
↓NF-kB
↓AP1
↓Loss of cell–cell contacts
↓Abnormalities in cell morphology
↓Cell death
↓Annexin V binding

Delgado-Wicke et al. [36]

Keratinocytes

↑Cell viability
↑Transcription of gene targets of the (NRF2) pathway
↓IL6 and IL8
↓Induction of melanin production

Gonzales et al. [38]

Fibroblasts
Keratinocytes

↑ Cell survival
↓DNA damage (H2AX and CPD)

Model

Effect of PLE following UV exposure

Mulero et al. [39]

Rat

↑Epidermal catalase
↑Epidermal glutathione peroxidase activity
↑Langerhans cells

Alcaraz et al. [26]

Mouse

↓Mast cells
↓Number of capillary loops
↓Dermal elastosis

Zattra et al. [40]

Mouse

↓Inflammatory infiltrates
↓Neutrophil infiltration ↓Macrophages
↓COX-2

Kohli et al. [22]

Human

↓COX-2
↓Erythema

Middelkamp-Hup et al. [20]

Human

↓Dermal mast cell infiltration

Villa et al. [21]

Human

↓Mitochondrial common deletion (trend)

Human

↓Mean FRAP
↓Lipid peroxidation
↑Radiance, moisture, elasticity and skin lightness

In vitro studies

References
In vivo studies

Granger et al. [44]a

AP1 activator protein 1, COX2 cyclooxygenase 2, CPD cyclobutane pyrimidine dimer, FRAP ferric reducing antioxidant power, H2AX H2A
histone family member X, H2O2 hydrogen peroxide, HSP heat shock protein, IL interleukin, i-NOS inducible nitric oxide synthase, LDH lactate
dehydrogenase, NF-kB nuclear factor KB, NRF2 nuclear factor erythroid 2-related factor 2, NO nitric oxide, MMP matrix metalloproteinase,
TGF-β tumor growth factor-β, TIMP tissue inhibitor of matrix metalloproteinase, TiO2 titanium dioxide, TNF-α tumor necrosis factor, UCAurocanic acid
a

Antioxidant food supplement containing a non-Fernblock extract of P. leucotomos
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Alonso-Lebrero et al. assessed the effects of PLE on
UVA-induced survival and proliferation of human dermal
fibroblasts and keratinocytes [31]. Fibroblast morphology
was also investigated under these conditions. Cells were
irradiated with either UVA or UVB and PLE doses of
0.1–2 mg/ml were used. Fibroblast survival with PLE was
compared to other antioxidants including N-acetylcysteine
(NAC), Trolox (a synthetic analog of α-tocopherol) or
ascorbic acid. PLE induced a noticeable, dose dependent increase in fibroblast survival after irradiation with
UVA at 1 J/cm2 when compared to untreated controls. The
other antioxidants preserved fibroblast survival above the
untreated controls, but were not as efficient as PLE. PLE
also improved the ability of fibroblasts to proliferate after
exposure to UVA (1 J/cm2). Compared to untreated, irradiated fibroblasts, PLE provided complete photoprotection up to 1 J/cm2 of UVA; the degree of photoprotection declined at doses higher than 1 J/cm2. PLE protected
against UVA-induced (1 J/cm2) cytoskeletal disorganization and abnormalities in adhesion molecule distribution
patterns. PLE with UVA doses of 10 J/cm2 and 15 J/cm2
and UVB at 10 mJ/cm2 demonstrated preserved keratinocyte survival. PLE also demonstrated a protective effect
on keratinocyte proliferation at UVA doses of 10 J/cm 2
and 15 J/cm2. The authors noted that the photoprotection
shown for both keratinocytes and fibroblasts suggests that
the specificity of PLE is not limited by cell lineage. PLE’s
ability to block UV-induced cytoskeletal rearrangements
also suggests that its photoprotective effect may not only
be due to regulation of DNA synthesis, but also cytoskeletal mechanisms [31].
Capote et al. evaluated the effect of various doses of
PLE on UVA and UVB-induced photoisomerization of
trans-urocanic acid (t-UCA; 0.5 mg/ml), a photoreceptor located in the stratum corneum [32]. The cis form of
urocanic acid is immunosuppressive and not photoprotective [33]. PLE significantly inhibited UVB (4.8 J/cm2) and
UVA-induced (6.48 J/cm2) formation of cis-UCA. TransUCA plus H
 2O2 irradiated with UVB (4.8 J/cm2) in the
presence of increasing concentrations of PLE (0–30 μg/
ml) demonstrated a dose-dependent decrease in cis-UCA
formation. H 2O 2 was used to simulate the presence of
endogenous hydroxyl radicals formed by UVB irradiation
[34]. TiO2 is known to generate reactive oxygen species
(ROS) upon exposure to UV. In the presence of TiO2, PLE
significantly decreased levels of UVA (6.48 J/cm2) induced
t-UCA photodecomposition. UVA-irradiated (1 J/cm 2)
fibroblasts in the presence of PLE demonstrated increased
cell survival when compared to untreated irradiated cells.
The results demonstrated that PLE may be able inhibit
UV-induced TiO2-dependent ROS production and photodecomposition of endogenous photoprotective molecules,
such as t-UCA [32].
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Janczyk et al. evaluated the effects of PLE 1 mg/ml
on levels of TNF-α, nitric oxide (NO), inducible nitric
oxide synthase (i-NOS), cell membrane damage and cell
death, and PLE 0.5–2 mg/ml on NF-kB and AP1 levels
in keratinocytes pre-treated with PLE and irradiated with
different doses of UVR. Doses of UVR varied depending
on the experiment (UVA 6 J⁄cm2 + UVB 0.5 J⁄cm2, UVA
11 J⁄cm2 + UVB 1 J⁄cm2 UVA = 2.4 J⁄cm2 + UVB = 0.2 J⁄c
m2) [35]. PLE pretreatment significantly decreased the upregulation of TNF-α, nitric oxide and inducible nitric oxide
synthase levels. Comparison of pre and post treatment with
PLE demonstrated a significant inhibition of UVR-induced
activation of NF-kB, AP1, and partial mitigation of loss of
cell–cell contacts, abnormalities in cell morphology, and cell
death. In PLE pretreated keratinocytes, a partial counteraction of UV-induced annexin V binding, a marker related
to apoptosis, was noted. These findings demonstrated the
anti-inflammatory and cell protective effects of PLE against
UVR [35].
Delgado-Wicke et al. evaluated the effect of PLE
(7.8–62.5 μg/ml) on keratinocytes pre-treated with PLE and
subsequently irradiated with UVB (90 mJ/cm2) or exposed
to PM2.5 (50 μg/ml), an experimental model of fine pollutant particles [36]. PLE was found to reduce the decrease in
UVB-induced viability of keratinocytes and to induce the
transcription of gene targets of the nuclear factor erythroid
2-related factor 2 (NRF2) pathway, which counteracts oxidative stress [37]. UVB-induced interleukin (IL)6 and IL8, as
well as induction of melanin production were all decreased
by PLE. Similarly, PLE partially reverted PM2.5-induced
toxicity of keratinocytes and upregulated NFR2 transcription
factor and some of its downstream antioxidant targets. This
study demonstrated how PLE protects against not only photooxidative stress but also other environmental pollutants.
Gonzales et al. evaluated the antioxidant capacity of
various extracts of Polypodiun leucotomas, and their effects
(1 mg/ml) on UV-induced cell viability and DNA damage
in human fibroblasts and keratinocytes irradiated with UVR
(2.2 J/cm2), though the spectral output was not stated in the
article [38]. A total of six extracts of Polypodium leucotomas (3 from the leaves and 3 from the rhizome portion)
were used in this study. The antioxidant moieties protocatechuic, vanillic, caffeic, and ferulic acid were also evaluated
by high performance liquid chromatography (HPLC). All
samples from the leaves and one sample from the rhizome
were found to have significant antioxidant activity as determined by 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic
acid) diammonium salt (ABTS) and ferric reducing antioxidant power (FRAP) assays. Samples 1 and 2, both from
leaves, were found to contain detectable amounts of these
antioxidant moieties. Samples 1 and 2 were also the most
effective in terms of improving cell survival and decreasing
DNA damage (decrease in γ-H2A histone family member X

Photochemical & Photobiological Sciences (2021) 20:1229–1238

(H2AX) and cyclobutane pyrimidine dimers (CPD)), with
sample 2 (Fernblock®) being most effective [38].

2.2 In vivo (murine)
Mulero et al. assessed the levels of antioxidants and Langerhans cells in the epidermis of hairless rats given oral PLE
at a concentration of 30 mg⁄ kg in drinking water for 7 days,
and subsequently irradiated with UVR (UVB⁄UVA-ratio of
0.9; peak at 312 nm;7 J⁄cm2) [39]. Dorsal skin biopsies taken
48 h after irradiation demonstrated a significant increase in
epidermal catalase and glutathione peroxidase activity when
compared to irradiated animals without PLE, and higher
numbers of Langerhans cells compared with the vehicletreated, irradiated group and the control, non-irradiated
group. These findings demonstrated the efficacy of PLE as
an oral antioxidant and photoimmunoprotective agent [39].
The effect of topical PLE on inflammation and histologic
parameters of photoaging in UVB-irradiated hairless albino
mice was studied by Alcaraz et al. [26] Mice were divided
into control non-irradiated, UVB-irradiated animals without PLE and animals that received topical application of
PLE either before (PLE 100 ml of 0.02%) or immediately
after (PLE 100 ml of 0.2%) each UVB exposure (cumulative 1.9 J/cm2 over 12 weeks). Mice treated with PLE
before UVB irradiation showed lower levels of mast cells
than those of irradiated control mice. PLE treated mice had
a lower number of capillary loops per square millimeter of
dermal area indicating decreased inflammation. Inhibition
of UV-induced dermal elastosis was also observed in mice
receiving topical PLE before and after each UVB irradiation
session. These findings demonstrated how PLE ameliorated
and partially inhibited some of the histologic damage associated with photoaging [26]. Zattra et al. evaluated the effect
of PLE on UVB-induced COX-2 expression and inflammation in the skin of hairless mice. Mice fed with PLE 300 mg/
kg for 10 days and exposed to UVB (25 mJ/cm2) experienced
a decrease in UVB-induced inflammatory infiltrates, neutrophil infiltration, macrophages and COX-2 [40].

2.3 In vivo (human)
Kohli et al.evaluated the effect of oral PLE on COX-2 in UV
irradiated skin of humans [22]. Twenty-two subjects with
Fitzpatrick skin phototype I to III were irradiated with UVB
(using 308-nm excimer laser) with doses ranging from 100
to 350 mJ/cm2. Pre-PLE minimal erythema dose (MED)/
trace erythema assessment and biopsy were performed 24 h
after irradiation. On day 3 subjects took PLE 240 mg 2 h
and 1 h (480 mg total) before irradiation was repeated as on
day 1. On day 4 a biopsy was taken from the site of MED/
trace erythema. A statistically significant decrease of COX-2
was found post-PLE consumption (p < 0.0005), indicating
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PLE’s anti-inflammatory effect. A significant improvement
in erythema was noted after PLE administration. Overall,
the results showed that PLE was able to lessen the negative
photobiologic effects of UVB [22]. Middelkamp-Hup et al.
studied the effects of PLE on dermal mast cell infiltration
after UV irradiation [20]. The back skin of nine participants
with Fitzpatrick skin phototype II and III were exposed to
UVR (305–400 nm) doses ranging up to 2–3 times the MED
dose, before and after taking PLE at different timepoints
[20]. After receiving an initial dose of UVR, initial biopsies
were taken from pre-PLE irradiated sites from 5 participants
after 24 h and from 2 participants 72 h after irradiation. The
evening before the second exposure of UVR, the first dose
of PLE (7.5 mg/kg) was given to participants. The next day,
a second dose of PLE was administered and participants
were exposed again at the same UVR fluences 30 min, 1 h,
1.5 h, 2 h and 3 h after the second dose of PLE. A second
biopsy was taken from the same participants who had an
initial biopsy done from the site at the timepoint showing
maximal photoprotection (5 participants after 24 h and 2
participants 72 h after irradiation.) Compared to pre-PLE
irradiated sites, a reduction in mast cells of the papillary
dermis was noted from biopsies taken from post-PLE irradiated sites at either 24 or 72 h after irradiation [20]. Mast cell
products are thought to play a role in photoaging by induction of fibroblast elastin production. The ability of PLE to
down-regulate UV-induced mast cell responses suggested
that PLE might play a role in reducing changes of photoaging [20, 41].
Villa et al. evaluated the effect of PLE on a photoagingassociated mitochondrial common deletion (CD) after UVA
irradiation (320–400 nm with a peak of 350 nm) [21]. In
this randomized, investigator-blinded, controlled trial, ten
participants with Fitzpatrick skin phototype II and III were
irradiated with UVA two to three times the MED (using
doses of 10–35 J/cm2) either having taken a single dose oral
PLE 480 mg before exposure or no PLE. Forearm biopsies
taken 24 h after irradiation demonstrated that at two times
the MED, the average CD values decreased by 84% in the
group taking PLE, compared to the 217% increase over baseline in the non-PLE treated group, trending toward significance (p = 0.06). The CD is a specific mitochondrial DNA
deletion induced by chronic UVA radiation in fibroblasts
and keratinocytes, and this study’s findings suggested that
PLE’s effect on photodamage may be through preventing
UVA-dependent mitochondrial DNA damage [21, 42, 43].
More recently, Granger et al. conducted a clinical trial
investigating the effects of an antioxidant food supplement containing a non-Fernblock extract of P. leucotomos on the antioxidant capacity and lipid peroxidation of
the skin after UVA irradiation. Thirty participants with
Fitzpatrick skin phototype I to III consumed 480 mg daily
for 12 weeks and UV irradiation was performed on the
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back skin at various timepoints over 12 weeks to achieve
one MED, with doses ranging from 38 to 41 mJ/cm2. The
mean Ferric Reducing Antioxidant Power (FRAP) measurement significantly decreased. Lipid peroxidation was
also measured via malondialdehyde (MDA) 4 h and 24 h
after UVA irradiation (5 J/cm 2) at each visit, and was
found to decrease with the supplement. Radiance, moisture, elasticity and skin lightness were also significantly
increased after supplementation. The authors concluded
that this supplement improved photoprotection, enhanced
the antioxidative status of the skin and improved general
skin condition [44].

3 Studies involving visible light and PLE
While most of the studies related to PLE and photoaging
have been done following exposure to UVR, PLE’s effects
on VL-induced photoaging has also been assessed in vitro in
human dermal fibroblasts and in vivo in humans (Table 2).

3.1 In vitro
Zamarron et al. assessed various photoaging markers in
human dermal fibroblasts pretreated with PLE (0.5–1 mg/
ml) and irradiated with VL [45]. Cells exposed to VL
(247.3 J/cm2) without PLE immediately showed signs of
cellular stress, such as cytoplasmic retraction and cellular
stretching. Cells exposed to VL in the presence of PLE

Table 2  Effects of Polypodium leucotomos extract on visible light-induced photoaging in vitro and in vivo
References

Cell types/substrates

Effect of
PLE following VL
exposure

In vitro studies
Zamarron et al. [45]

Fibroblasts

Delayed
morphologic
abnormalities
↓MMP-1
↓Cell death
rates
↓CathepsinK (trend)
↑Fibrillins
↑Elastin

References

Model

Effect of
PLE following VL
exposure

In vivo studies
Mohammad et al. [47]

Human

Truchuelo et al. [48]

Human

↓COX-2
↓MMP-2
(trend)
↓MART-1
(trend)
↓MMP-1
(trend)
↓MMP-9
(trend)
↓Persistent
pigment
darkening
↓Delayed
tanning
↓MMP-1

COX2 cyclooxygenase 2, MART-1 melanoma antigen recognized by T cells 1, MMP matrix metalloproteinase
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showed similar morphological findings; however, these were
not observed until 24 h after irradiation. PLE also decreased
MMP-1 expression compared to that seen in non-PLE treated
cells, decreased cell death rates to levels of non-irradiated
control cells, and trended toward a decrease in expression
of cathepsin-K, a lysosomal cysteine protease that degrades
collagen [46]. Fibrillins, structural components of extracellular microfibrils, generally increased with PLE treatment
after VL exposure. When compared to control non-irradiated
fibroblasts, a significant increase in elastin expression was
noted in irradiated fibroblasts, PLE-treated non-irradiated
fibroblasts and PLE-treated irradiated fibroblasts. Elastin
expression was highest in the highest PLE treatment group.
These results indicated that PLE helps prevent VL-induced
fibroblast damage, reduces VL-induced ECM degradation
enzyme expression and minimizes alterations in VL-induced
ECM protein expression [45].

3.2 In vivo (human)
Mohammad et al. evaluated the effects of oral PLE on VLinduced photoaging markers. In this prospective clinical
trial, 22 volunteers with Fitzpatrick skin types IV through VI
were irradiated on their backs with VL doses up to 480 J/cm2
after administration of 480 mg of PLE per day for 28 days.
A statistically significant decrease in COX-2 was reported in
PLE treatment skin compared to that irradiated without PLE
(p = 0.027). A strong trend towards reduction in MMP-2 was
noted, along with a weak trend towards reduction in melanoma antigen recognized by T cells 1 (MART-1), a melanocytic marker used to assess pigmentation, MMP-1, and
MMP-9. Spectroscopic assessments demonstrated a decrease
in post-PLE persistent pigment darkening and delayed tanning. These findings reflected the ability of PLE to mitigate
VL-induced inflammation, structural integrity and pigmentation [47].
Truchuelo et al. investigated the effect of oral PLE on
MMP-1 after irradiation with VL and infrared (IR). In this
prospective clinical trial of 7 volunteers, gluteal biopsies
were performed on skin irradiated with a single dose of VL
(200 J/cm2) + IR (600 J/cm2) before and after taking a total
oral dose of 960 mg per day of PLE for 21 days. A statistically significant global reduction of MMP-1 expression was
noted by 52%, reflecting PLE’s ability to mitigate photoaging-related ECM degradation [48].

4 Discussion
Many of the photoprotective effects of PLE in the studies
described above are related to its ability to prevent UV and
VL-induced ECM degradation by regulating factors involved
in ECM remodeling. PLE has been shown to stimulate tissue
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inhibitor of metalloproteinases (TIMPs), TGF-β and Type I,
III and V collagen expression in fibroblasts [28] In addition to
decreasing MMP-1 expression in keratinocytes and MMP-2
in fibroblasts, PLE also inhibits levels of MMP-1, 3, and 9
enzymes themselves [10, 28]. PLE-induced reinforcement of
the dermal elastic fiber network in mouse skin and increased
elastin expression in VL-irradiated fibroblasts support PLE’s
potential photoprotective role in counteracting photo-induced
elastosis [45, 49]. PLE is well-known for its antioxidative
properties which likely also contribute to ECM homeostasis. Rich in polyphenols, such as ferulic and caffeic acid, P.
leucotomos has been found to scavenge ROS and inhibit UV
radiation-induced ROS [50]. In vivo, PLE increases catalase
and glutathione peroxidase activity in mice skin [39]. PLE also
increases the levels of plasma antioxidants, such as superoxide
dismutase (SOD), glutathione S-transferase (GST), and GSH
peroxidase (GPx) which likely provides a reservoir of antioxidants to the skin [49, 51, 52].
PLE’s anti-inflammatory properties are demonstrated
through its inhibition of UV-induced immunosuppression
and inflammatory cells, likely leading to further inhibition
of ROS and generation of prostaglandin metabolites, such
as COX-2 [22, 26, 32]. The decrease in UVR-induced TNFα, NO, iNOS, NF-kB and AP1 in keratinocytes by PLE are
a reflection of its anti-inflammatory anti-apoptotic effects
[35, 53, 54]. PLE may also exert its photoprotective effects
via the prevention of UV-induced cytoskeletal derangements
[31]. In addition, the effect of PLE on phototoxicity and
environmental pollutants via the NFR2 antioxidant pathway
evidence a possible mechanism by which PLE may protect
against other environmental insults that can cause skin aging
[36].
Oral PLE is generally well tolerated with minimal adverse
effects [51, 52]. The ability of PLE to inhibit the deleterious effect of UV-exposed TiO2 on t-UCA and UVA/TiO2induced fibroblast cell death mediated by ROS generation
may make it an appropriate adjunct to use in sunscreen
formulations [32]. While the studies reviewed above demonstrate several photoprotective properties of PLE, most
were done in vitro or with animals. The amount and modes
of delivery of PLE as well as doses and forms of radiation
differed among studies. Very few studies have been done
related to PLE and VL-induced photoaging. Clearly, future
large-scale studies assessing the photoprotective effects of
oral and topical PLE in humans using natural sunlight over
longer periods of time are warranted.

5 Conclusion
P. leucotomos may protect against UV and VL-induced
photoaging of the skin through regulation of enzymes
involved in ECM remodeling, upregulation of ECM
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proteins, downregulation of inflammation and ROS due
to its anti-inflammatory and antioxidant properties and
cytoprotective effects on fibroblasts and keratinocytes. P.
leucotomos extract is a well-tolerated and safe agent with
photoprotective properties, making it potentially a suitable
adjunct in combating UVR and VL-induced skin aging.
Author contributions All authors whose names appear on the submission: 1. Made substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data; or
the creation of new software used in the work; 2. Drafted the work or
revised it critically for important intellectual content; 3. Approved the
version to be published; and; 4. Agree to be accountable for all aspects
of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Funding None provided.
Availability of data and materials Not applicable.
Code availability Not applicable.

Declarations
Conflict of interest Henry W. Lim has served as investigator/co-investigator for research studies sponsored by Incyte, L’Oréal, Pfizer, and
PCORI; he has served as a consultant for Pierre Fabre, ISDIN, Ferndale, Galderma, La Roche-Posay, and Beiersdorf; he has been a speaker on general education sessions for La Roche-Posay, and Cantabria
Labs. Iltefat Hamzavi has served as an advisory board member for AbbVie; a consultant for Incyte, Pfizer, and UCB; a principal investigator
for AbbVie, Allergan, Bayer, Clinuvel Pharmaceuticals, Este Lauder,
Ferndale Laboratories, Galderma Laboratories LP, GE Healthcare, Incyte, Janssen, Janssen Biotech, Johnson & Johnson, Lenicura, LEO
Pharma, Pfizer, and Unigen; a subinvestigator for Amgen, BristolMyers Squibb, Foamix Pharmaceuticals, and Janssen; president of
the HS Foundation; and co-chair of the Global Vitiligo Foundation.
Indermeet Kohli is an Investigator for Ferndale, Estee Lauder, L’Oreal,
Unigen, Johnson and Johnson, Allergan and Bayer with grant received
by the institution and is a Consultant for Pfizer, Johnson and Johnson,
and Bayer with fee and equipment received by the institution. Aunna
Pourang is a subinvestigator for Pfizer, Biofrontera and L’Oreal. Nneamaka Ezekwe is a subinvestigator for Pfizer, Biofrontera and L’Oreal.
Mohsen Dourra has no conflicts of interest or disclosures.
Ethical approval Not applicable.
Humans and animals rights Not applicable.
Consent to participate Not applicable.
Consent for publication Not applicable.

References
1. Frederick, J. E., Snell, H. E., & Haywood, E. K. (1989). Solar
ultraviolet radiation at the earth’s surface. Photochemistry and
Photobiology, 50(4), 443–450.

13

Photochemical & Photobiological Sciences (2021) 20:1229–1238
2. Scharffetter-Kochanek, K., Brenneisen, P., Wenk, J., et al. (2000).
Photoaging of the skin from phenotype to mechanisms. Experimental Gerontology, 35(3), 307–316.
3. Fisher, G. J., Wang, Z. Q., Datta, S. C., Varani, J., Kang, S., &
Voorhees, J. J. (1997). Pathophysiology of premature skin aging
induced by ultraviolet light. New England Journal of Medicine,
337(20), 1419–1428.
4. Fisher, G. J., Kang, S., Varani, J., et al. (2002). Mechanisms of
photoaging and chronological skin aging. Archives of Dermatology, 138(11), 1462–1470.
5. Cho, S., Lee, M. J., Kim, M. S., et al. (2008). Infrared plus visible
light and heat from natural sunlight participate in the expression
of MMPs and type I procollagen as well as infiltration of inflammatory cell in human skin in vivo. Journal of Dermatological
Science, 50(2), 123–133.
6. Liebel, F., Kaur, S., Ruvolo, E., Kollias, N., & Southall, M. D.
(2012). Irradiation of skin with visible light induces reactive
oxygen species and matrix-degrading enzymes. The Journal of
Investigative Dermatology, 132(7), 1901–1907.
7. Rinnerthaler, M., Bischof, J., Streubel, M. K., Trost, A., & Richter,
K. (2015). Oxidative stress in aging human skin. Biomolecules,
5(2), 545–589.
8. Nishigori, C. (2006). Cellular aspects of photocarcinogenesis.
Photochemical and Photobiological Sciences, 5(2), 208–214.
9. Gonzalez, S., & Pathak, M. A. (1996). Inhibition of ultravioletinduced formation of reactive oxygen species, lipid peroxidation,
erythema and skin photosensitization by Polypodium leucotomos.
Photodermatology, Photoimmunology and Photomedicine, 12(2),
45–56.
10. Philips, N., Smith, J., Keller, T., & Gonzalez, S. (2003). Predominant effects of Polypodium leucotomos on membrane integrity,
lipid peroxidation, and expression of elastin and matrixmetalloproteinase-1 in ultraviolet radiation exposed fibroblasts, and
keratinocytes. Journal of Dermatological Science., 32(1), 1–9.
11. Yaar, M., & Gilchrest, B. A. (2007). Photoageing: Mechanism,
prevention and therapy. British Journal of Dermatology, 157(5),
874–887.
12. Philips, N., & Gonzalez, S. (2013). Beneficial regulation of
elastase activity and expression of tissue inhibitors of matrixmetalloproteinases, fibrillin, transforming growth factor-P. leucotomos in nonirradiated or ultraviolet-radiated epidermal keratinocytes. ISRN Oxidative Medicine, 2013, 257463.
13. Kligman, L. H., & Gebre, M. (1991). Biochemical changes in hairless mouse skin collagen after chronic exposure to ultraviolet-A
radiation. Photochemistry and Photobiology, 54(2), 233–237.
14. Kaarsen, L. L., Poulsen, T. D., de Fine, O. F., & Wulf, H. C.
(1995). Mast cells and elastosis in ultraviolet-irradiated hairless
mice. Photodermatology, Photoimmunology and Photomedicine,
11(1), 1–5.
15. Lyons, A. B., Trullas, C., Kohli, I., Hamzavi, I. H., & Lim, H. W.
(2020). Photoprotection beyond ultraviolet radiation: A review of
tinted sunscreens. Journal of the American Academy of Dermatology, 84, 1393–1397.
16. Schneider, S. L., & Lim, H. W. (2019). Review of environmental effects of oxybenzone and other sunscreen active ingredients. Journal of the American Academy of Dermatology, 80(1),
266–271.
17. Garcia, F., Pivel, J. P., Guerrero, A., et al. (2006). Phenolic components and antioxidant activity of Fernblock, an aqueous extract
of the aerial parts of the fern Polypodium leucotomos. Methods
and Findings in Experimental and Clinical Pharmacology, 28(3),
157–160.
18. Choudhry, S. Z., Bhatia, N., Ceilley, R., et al. (2014). Role of
oral Polypodium leucotomos extract in dermatologic diseases: A
review of the literature. Journal of Drugs in Dermatology, 13(2),
148–153.

Photochemical & Photobiological Sciences (2021) 20:1229–1238
19. FERNBLOCK® Patented Extract of Polypodium leucotomos.
(2020). https://www.cantabrialabsdifacooper.it/tecnologie/fernb
lock/. Accessed 26 Aug 2020.
20. Middelkamp-Hup, M. A., Pathak, M. A., Parrado, C., et al.
(2004). Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. Journal of the American
Academy of Dermatology, 51(6), 910–918.
21. Villa, A., Viera, M. H., Amini, S., et al. (2010). Decrease of
ultraviolet A light-induced “common deletion” in healthy volunteers after oral Polypodium leucotomos extract supplement in
a randomized clinical trial. Journal of the American Academy
of Dermatology, 62(3), 511–513.
22. Kohli, I., Shafi, R., Isedeh, P., et al. (2017). The impact of oral
Polypodium leucotomos extract on ultraviolet B response: A
human clinical study. Journal of the American Academy of Dermatology, 77(1), 33-41 e31.
23. Gonzalez, S., Pathak, M. A., Cuevas, J., Villarrubia, V. G., &
Fitzpatrick, T. B. (1997). Topical or oral administration with an
extract of Polypodium leucotomos prevents acute sunburn and
psoralen-induced phototoxic reactions as well as depletion of
Langerhans cells in human skin. Photodermatology, Photoimmunology and Photomedicine, 13(1–2), 50–60.
24. Tanew, A., Radakovic, S., Gonzalez, S., Venturini, M., &
Calzavara-Pinton, P. (2012). Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of
polymorphic light eruption. Journal of the American Academy
of Dermatology, 66(1), 58–62.
25. Caccialanza, M., Recalcati, S., & Piccinno, R. (2011). Oral
Polypodium leucotomos extract photoprotective activity in 57
patients with idiopathic photodermatoses. Giornale Italiano di
Dermatologia e Venereologia, 146(2), 85–87.
26. Alcaraz, M. V., Pathak, M. A., Rius, F., Kollias, N., & González,
S. (1999). An extract of Polypodium leucotomos appears to minimize certain photoaging changes in a hairless albino mouse
animal model: A pilot study. Photodermatology, Photoimmunology and Photomedicine, 15(3–4), 120–126.
27. Parrado, C., Mascaraque, M., Gilaberte, Y., Juarranz, A., &
Gonzalez, S. (2016). Fernblock (Polypodium leucotomos
extract): molecular mechanisms and pleiotropic effects in lightrelated skin conditions, photoaging and skin cancers, a review.
International Journal of Molecular Sciences, 17(7), 1026.
28. Philips, N., Conte, J., Chen, Y. J., et al. (2009). Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar
collagens and transforming growth factor-beta by Polypodium
leucotomos, directly or in dermal fibroblasts, ultraviolet radiated
fibroblasts, and melanoma cells. Archives of Dermatological
Research, 301(7), 487–495.
29. Jonak, C., Mildner, M., Klosner, G., et al. (2011). The hsp27kD
heat shock protein and p38-MAPK signaling are required for
regular epidermal differentiation. Journal of Dermatological
Science, 61(1), 32–37.
30. Matsuda, M., Hoshino, T., Yamashita, Y., et al. (2010). Prevention of UVB radiation-induced epidermal damage by expression of heat shock protein 70. Journal of Biological Chemistry,
285(8), 5848–5858.
31. Alonso-Lebrero, J. L., Dominguez-Jimenez, C., Tejedor, R.,
Brieva, A., & Pivel, J. P. (2003). Photoprotective properties
of a hydrophilic extract of the fern Polypodium leucotomos on
human skin cells. Journal of Photochemistry and Photobiology
B, 70(1), 31–37.
32. Capote, R., Alonso-Lebrero, J. L., Garcia, F., Brieva, A., Pivel,
J. P., & Gonzalez, S. (2006). Polypodium leucotomos extract
inhibits trans-urocanic acid photoisomerization and photodecomposition. Journal of Photochemistry and Photobiology B,
82(3), 173–179.

1237
33. Finlay-Jones, J. J., & Hart, P. H. (1998). Photoprotection: Sunscreens and the immunomodulatory effects of UV irradiation.
Mutation Research, 422(1), 155–159.
34. Kammeyer, A., Eggelte, T. A., Overmars, H., Bootsma, A., Bos,
J. D., & Teunissen, M. B. (2001). Oxidative breakdown and conversion of urocanic acid isomers by hydroxyl radical generating
systems. Biochimica et Biophysica Acta, 1526(3), 277–285.
35. Janczyk, A., Garcia-Lopez, M. A., Fernandez-Penas, P., et al.
(2007). A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TNF-alpha and iNOS expression, transcriptional activation and apoptosis. Experimental Dermatology,
16(10), 823–829.
36. Delgado-Wicke, P., Rodríguez-Luna, A., Ikeyama, Y., et al.
(2020). Fernblock® upregulates NRF2 antioxidant pathway and
protects keratinocytes from PM25-induced xenotoxic stress. Oxidative Medicine and Cellular Longevity, 2020, 2908108.
37. Marrot, L., Jones, C., Perez, P., & Meunier, J. R. (2008). The significance of Nrf2 pathway in (photo)-oxidative stress response in
melanocytes and keratinocytes of the human epidermis. Pigment
Cell and Melanoma Research, 21(1), 79–88.
38. Salvador, G., Silvia, R. L., Pablo, D., & Angeles, J. (2018). Comparison of several hydrophilic extracts of Polypodium leucotomos
reveals different antioxidant moieties and photoprotective effects
in vitro. Journal of Medicinal Plants Research, 12(22), 336–345.
39. Mulero, M., Rodriguez-Yanes, E., Nogues, M. R., et al. (2008).
Polypodium leucotomos extract inhibits glutathione oxidation and
prevents Langerhans cell depletion induced by UVB/UVA radiation in a hairless rat model. Experimental Dermatology, 17(8),
653–658.
40. Zattra, E., Coleman, C., Arad, S., et al. (2009). Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice. American Journal of Pathology, 175(5), 1952–1961.
41. Gonzalez, S., Moran, M., & Kochevar, I. E. (1999). Chronic photodamage in skin of mast cell-deficient mice. Photochemistry and
Photobiology, 70(2), 248–253.
42. Berneburg, M., Grether-Beck, S., Kurten, V., et al. (1999). Singlet
oxygen mediates the UVA-induced generation of the photoagingassociated mitochondrial common deletion. Journal of Biological
Chemistry, 274(22), 15345–15349.
43. Berneburg, M., Plettenberg, H., Medve-Konig, K., et al. (2004).
Induction of the photoaging-associated mitochondrial common
deletion in vivo in normal human skin. The Journal of Investigative Dermatology, 122(5), 1277–1283.
44. Granger, C., Aladren, S., Delgado, J., Garre, A., Trullas, C., &
Gilaberte, Y. (2020). Prospective evaluation of the efficacy of a
food supplement in increasing photoprotection and improving
selective markers related to skin photo-ageing. Dermatology and
Therapy (Heidelberg), 10(1), 163–178.
45. Zamarron, A., Lorrio, S., Gonzalez, S., & Juarranz, A. (2018).
Fernblock prevents dermal cell damage induced by visible and
infrared A radiation. International Journal of Molecular Sciences,
19(8), 2250.
46. Quintanilla-Dieck, M. J., Codriansky, K., Keady, M., Bhawan, J.,
& Runger, T. M. (2009). Expression and regulation of cathepsin
K in skin fibroblasts. Experimental Dermatology, 18(7), 596–602.
47. Mohammad, T. F., Kohli, I., Nicholson, C. L., et al. (2019). Oral
Polypodium leucotomos extract and its impact on visible lightinduced pigmentation in human subjects. Journal of Drugs in
Dermatology, 18(12), 1198–1203.
48. Truchuelo, M., Jiménez, N., Días, I., Gallego-Rentero, M.,
Alonso-Juarranz, M., & Gonzalez, S. (2019). A pilot study to
assess the effects of an oral photo protector of botanical origin
against visible and infrared radiations in human volunteers. Dermatology and Dermatologic Diseases, 6(2), 1–3.

13

1238
49. Rodriguez-Yanes, E., Juarranz, A., Cuevas, J., Gonzalez, S., &
Mallol, J. (2012). Polypodium leucotomos decreases UV-induced
epidermal cell proliferation and enhances p53 expression and
plasma antioxidant capacity in hairless mice. Experimental Dermatology, 21(8), 638–640.
50. Gomes, A. J., Lunardi, C. N., Gonzalez, S., & Tedesco, A. C.
(2001). The antioxidant action of Polypodium leucotomos extract
and kojic acid: Reactions with reactive oxygen species. Brazilian
Journal of Medical and Biological Research, 34, 1487–1494.
51. Murbach, T. S., Beres, E., Vertesi, A., et al. (2015). A comprehensive toxicological safety assessment of an aqueous extract of
Polypodium leucotomos (Fernblock((R))). Food and Chemical
Toxicology, 86, 328–341.

13

Photochemical & Photobiological Sciences (2021) 20:1229–1238
52. Nestor, M. S., Berman, B., & Swenson, N. (2015). Safety and
efficacy of oral Polypodium leucotomos extract in healthy adult
subjects. The Journal of Clinical and Aesthetic Dermatology, 8(2),
19–23.
53. Kroncke, K. D., Fehsel, K., Suschek, C., & Kolb-Bachofen, V.
(2001). Inducible nitric oxide synthase-derived nitric oxide in
gene regulation, cell death and cell survival. International Immunopharmacology, 1(8), 1407–1420.
54. Ware, C. F., VanArsdale, S., & VanArsdale, T. L. (1996). Apoptosis mediated by the TNF-related cytokine and receptor families.
Journal of Cellular Biochemistry, 60(1), 47–55.

